Core Laboratories (CLB) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CORE LAB REPORTS SECOND QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS
July 27, 2022 5:15 PM EDTSECOND QUARTER REVENUE OF $120.9 MILLION; UP 5% SEQUENTIALLY; UP 2% YEAR-OVER-YEARSECOND QUARTER SEQUENTIAL INCREMENTAL MARGINS, EX-ITEMS, 43%, DRIVEN BY RESERVOIR DESCRIPTIONSECOND QUARTER GAAP EPS OF $0.15; EPS, EX-ITEMS, $0.12RENEWS AND EXTENDS REVOLVING CREDIT FACILITY THROUGH 2026ANNOUNCES Q3 2022 QUARTERLY DIVIDEND
AMSTERDAM, July 27, 2022 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported second quarter 2022 revenue of $120,900,000. Sequential revenue growth was adversely impacted by approximately... More
